Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
Construct winning strategies that anticipate where value will lie. In Vivo’s in-depth analysis spans influential deals, R&D, commercial and market access strategies.
How it helps
With In Vivo, you’ll benefit from:
How it works
Access mission-critical information via a simple-to-use interface. And if you need to need to find out more about developments or pharmaceutical industry trends to support presentations, proposals or business-critical decisions, you can access our worldwide network of expert analysts through our acclaimed Ask-the-Analyst™ service.
Plus, you can identify threats and opportunities using our Execs on the Move feature, which tracks the company movements of senior executives.
In Vivo, Medtech Insight
Join distinguished cancer and industry experts as they explore what a shift in cancer treatment – from late stage intervention to an early detection paradigm – would mean for patient outcomes, cancer costs, technology, development, regulatory affairs, and more. Explore this new approach toward focusing on early stage cancer detection, including discussion of diagnostics in this area, such as biomarker identification, liquid biopsies, and monitoring technologies.
Topic Diagnostics Cancer
In Vivo, Scrip
2020 coverage from Scrip and In Vivo provides rich insights into the attitudes and trends around deals and financing, two major engines of innovation and growth for biopharma during this current pandemic period.
In Vivo, Medtech Insight, Pink Sheet, Scrip
Explore how digital technologies are being used to address the disruption of clinical trials for drugs and medical technology caused by COVID-19. Stay current with insights from industry leaders, information on guidance and regulation, and an examination of how the challenges of this global crisis and the industry’s response to it may soon usher in a new era in worldwide healthcare.
Topic Coronavirus
In Vivo
As night turned to day on June 24, it became clearer by the hour that the unthinkable had happened, and the UK’s long and acrimonious debate about its 43-year membership of the European Union had ended in a victory for the Leave group. The local health care products industries made their views clear some weeks ago, but today and in the months to come, they will have to confront a Plan B that was never in the plans.
Topic Market Access Brexit
Pink Sheet, Scrip, In Vivo
Keep up with advances in the critically important, emerging area of gene therapy. This transformative new category of medicines has the potential to treat more diseases – including complex and rare diseases – with longer-lasting effects than traditional medicines.
Topic Research & Development Deals
In Vivo
Your snapshot view of how the life sciences in nations around the globe are responding to the COVID-19 pandemic is now available. Register today to receive your free World Vision 360° infographic from In Vivo.
In Vivo
Get a global perspective on the current state of the pharma and medtech industries with In Vivo’s World Vision 360° article pack. Access your free pack for essential insights into research and development, innovations, trends and strategies for markets around the world.
In Vivo
Johan Van Hoof, global head of vaccines at Janssen, talks to In Vivo about the company’s platform, how it is approaching COVID-19 research and the impact of today’s global pandemic on the future of vaccine R&D.
Topic Coronavirus Vaccines
In Vivo
The use of virtual, real-time and at-home testing to provide clinical trials data has been steadily gaining the interest of the health care industry. COVID-19 has put this opportunity into sharper focus, says CNS trials technology developer Cambridge Cognition, which is now adding a voice option to its portfolio.
Topic Coronavirus Clinical Trials
In Vivo
The COVID-19 pandemic is disrupting global supply chains and companies need effective tools to manage the related contract disputes. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, provide tips to help companies manage the situation.
In Vivo
Adoption of telehealth services has skyrocketed during the coronavirus outbreak and US experts are expecting the trend to continue post-pandemic, fundamentally transforming health care.
Topic Coronavirus Digital Health
In Vivo
In Vivo brings you another exclusive look into the future of biopharma, medtech and healthtech with our new article pack that features interviews with rising leaders and established executives, all sharing their insight. Download your free pack for a view of how today’s rising leaders are shaping the life sciences industries of tomorrow.
Topic Leadership Medtech
In Vivo
Find out who is coming through the ranks of biopharma, medtech and healthtech organizations with In Vivo’s infographic, “30 Rising Leaders of 2020”. Your free infographic provides a snapshot view of the entrepreneurs and innovators who are moving their industries forward with creative thinking and new technologies.
Topic Leadership Medtech
In Vivo
As the global shut-down caused by the coronavirus pandemic continues, sponsors are rushing to adapt clinical trials that can move to partial or completely remote monitoring, allowing patients to remain in their homes but continue to participate in studies. And the outbreak may have another silver lining for the biopharma industry, a chance to rebuild its reputation.
Topic Coronavirus
In Vivo
Evan Loh, CEO of infectious disease drug developer Paratek Pharmaceuticals, explains why eliminating the DISARM ACT, which focused on finding solutions against antimicrobial resistance, from the new coronavirus aid package is a shortsighted move by US congress.
Topic Coronavirus
In Vivo
26 Oct 2020
In Vivo
23 Oct 2020
In Vivo
21 Oct 2020
In Vivo
19 Oct 2020
In Vivo
14 Oct 2020
In Vivo
14 Oct 2020
In Vivo
14 Oct 2020
In Vivo
13 Oct 2020
In Vivo
07 Oct 2020
In Vivo
05 Oct 2020
In Vivo
05 Oct 2020
In Vivo
05 Oct 2020
In Vivo
30 Sep 2020
In Vivo
30 Sep 2020
In Vivo
30 Sep 2020
USA
William specializes in
+40 year(s) experience
Washington DC, USA
Cathy specializes in
+39 year(s) experience
Washington DC, USA
Denise specializes in
+38 year(s) experience
Support the development and validation of your strategic plans and ensure commercial decisions are based on marketplace realities. Datamonitor Healthcare offers expert coverage of key diseases, treatments, companies, drugs, market access and market trends. Our primary research with physicians, payers, and KOLs (key opinion leaders) informs our treatment standards data and patient-based forecasts.
You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.
In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.
Looking for more products Product Finder
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
